vs
Side-by-side financial comparison of CIMPRESS plc (CMPR) and Incyte (INCY). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× CIMPRESS plc). Incyte runs the higher net margin — 23.8% vs 4.7%, a 19.1% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 11.0%).
Cimpress plc is an American Irish-domiciled multinational technology company that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods. Those products are sold to small businesses, graphic designers and consumers through a number of customer-facing brands that Cimpress operates.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
CMPR vs INCY — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.3B |
| Net Profit | $49.3M | $303.3M |
| Gross Margin | 46.8% | — |
| Operating Margin | 8.5% | 23.7% |
| Net Margin | 4.7% | 23.8% |
| Revenue YoY | 11.0% | 20.9% |
| Net Profit YoY | -19.2% | 91.7% |
| EPS (diluted) | $1.95 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $863.3M | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.0B |
| Q1 26 | — | $303.3M | ||
| Q4 25 | $49.3M | $299.3M | ||
| Q3 25 | $7.6M | $424.2M | ||
| Q2 25 | — | $405.0M | ||
| Q1 25 | — | $158.2M | ||
| Q4 24 | — | $201.2M | ||
| Q3 24 | — | $106.5M | ||
| Q2 24 | — | $-444.6M |
| Q1 26 | — | — | ||
| Q4 25 | 46.8% | 92.0% | ||
| Q3 25 | 46.7% | 92.8% | ||
| Q2 25 | — | 93.5% | ||
| Q1 25 | — | 93.0% | ||
| Q4 24 | — | 92.5% | ||
| Q3 24 | — | 92.4% | ||
| Q2 24 | — | 92.7% |
| Q1 26 | — | 23.7% | ||
| Q4 25 | 8.5% | 22.3% | ||
| Q3 25 | 5.7% | 32.5% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 12.8% | ||
| Q2 24 | — | -45.8% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | 4.7% | 19.9% | ||
| Q3 25 | 0.9% | 31.1% | ||
| Q2 25 | — | 33.3% | ||
| Q1 25 | — | 15.0% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | 9.4% | ||
| Q2 24 | — | -42.6% |
| Q1 26 | — | $1.47 | ||
| Q4 25 | $1.95 | $1.46 | ||
| Q3 25 | $0.30 | $2.11 | ||
| Q2 25 | — | $2.04 | ||
| Q1 25 | — | $0.80 | ||
| Q4 24 | — | $0.90 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | — | $-2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $258.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-530.7M | $5.6B |
| Total Assets | $2.1B | $7.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $258.0M | $3.1B | ||
| Q3 25 | $200.5M | $2.5B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $987.3M |
| Q1 26 | — | $5.6B | ||
| Q4 25 | $-530.7M | $5.2B | ||
| Q3 25 | $-571.3M | $4.7B | ||
| Q2 25 | — | $4.2B | ||
| Q1 25 | — | $3.7B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.0B |
| Q1 26 | — | $7.3B | ||
| Q4 25 | $2.1B | $7.0B | ||
| Q3 25 | $2.0B | $6.3B | ||
| Q2 25 | — | $5.8B | ||
| Q1 25 | — | $5.7B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | — | $4.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $164.7M | — |
| Free Cash FlowOCF − Capex | $139.5M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | 3.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $164.7M | $543.3M | ||
| Q3 25 | $25.1M | $559.4M | ||
| Q2 25 | — | $44.7M | ||
| Q1 25 | — | $266.1M | ||
| Q4 24 | — | $381.2M | ||
| Q3 24 | — | $310.9M | ||
| Q2 24 | — | $-575.6M |
| Q1 26 | — | — | ||
| Q4 25 | $139.5M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 13.4% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.34× | 1.82× | ||
| Q3 25 | 3.28× | 1.32× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.89× | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMPR
| Vista | $532.8M | 51% |
| Print Brothers | $219.9M | 21% |
| National Pen | $150.9M | 14% |
| The Print Group | $115.2M | 11% |
| All Other Businesses | $67.2M | 6% |
INCY
Segment breakdown not available.
